Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2013 1
2017 1
2018 3
2019 2
2021 1
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Enhanced detection of circulating tumor DNA by fragment size analysis.
Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, Mair R, Goranova T, Marass F, Heider K, Wan JCM, Supernat A, Hudecova I, Gounaris I, Ros S, Jimenez-Linan M, Garcia-Corbacho J, Patel K, Østrup O, Murphy S, Eldridge MD, Gale D, Stewart GD, Burge J, Cooper WN, van der Heijden MS, Massie CE, Watts C, Corrie P, Pacey S, Brindle KM, Baird RD, Mau-Sørensen M, Parkinson CA, Smith CG, Brenton JD, Rosenfeld N. Mouliere F, et al. Sci Transl Med. 2018 Nov 7;10(466):eaat4921. doi: 10.1126/scitranslmed.aat4921. Sci Transl Med. 2018. PMID: 30404863 Free PMC article.
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer.
Heitzer E, van den Broek D, Denis MG, Hofman P, Hubank M, Mouliere F, Paz-Ares L, Schuuring E, Sültmann H, Vainer G, Verstraaten E, de Visser L, Cortinovis D. Heitzer E, et al. Among authors: mouliere f. ESMO Open. 2022 Apr;7(2):100399. doi: 10.1016/j.esmoop.2022.100399. Epub 2022 Feb 21. ESMO Open. 2022. PMID: 35202954 Free PMC article. Review.
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.
Crispin-Ortuzar M, Woitek R, Reinius MAV, Moore E, Beer L, Bura V, Rundo L, McCague C, Ursprung S, Escudero Sanchez L, Martin-Gonzalez P, Mouliere F, Chandrananda D, Morris J, Goranova T, Piskorz AM, Singh N, Sahdev A, Pintican R, Zerunian M, Rosenfeld N, Addley H, Jimenez-Linan M, Markowetz F, Sala E, Brenton JD. Crispin-Ortuzar M, et al. Among authors: mouliere f. Nat Commun. 2023 Oct 24;14(1):6756. doi: 10.1038/s41467-023-41820-7. Nat Commun. 2023. PMID: 37875466 Free PMC article.
Cell-free DNA technologies for the analysis of brain cancer.
Mair R, Mouliere F. Mair R, et al. Among authors: mouliere f. Br J Cancer. 2022 Feb;126(3):371-378. doi: 10.1038/s41416-021-01594-5. Epub 2021 Nov 22. Br J Cancer. 2022. PMID: 34811503 Free PMC article. Review.
Circulating cell free DNA: Preanalytical considerations.
El Messaoudi S, Rolet F, Mouliere F, Thierry AR. El Messaoudi S, et al. Among authors: mouliere f. Clin Chim Acta. 2013 Sep 23;424:222-30. doi: 10.1016/j.cca.2013.05.022. Epub 2013 May 30. Clin Chim Acta. 2013. PMID: 23727028 Review.
Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis.
Moldovan N, van der Pol Y, van den Ende T, Boers D, Verkuijlen S, Creemers A, Ramaker J, Vu T, Bootsma S, Lenos KJ, Vermeulen L, Fransen MF, Pegtel M, Bahce I, van Laarhoven H, Mouliere F. Moldovan N, et al. Among authors: mouliere f. Cell Rep Med. 2024 Jan 16;5(1):101349. doi: 10.1016/j.xcrm.2023.101349. Epub 2023 Dec 20. Cell Rep Med. 2024. PMID: 38128532 Free PMC article.
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.
Coombes RC, Badman PD, Lozano-Kuehne JP, Liu X, Macpherson IR, Zubairi I, Baird RD, Rosenfeld N, Garcia-Corbacho J, Cresti N, Plummer R, Armstrong A, Allerton R, Landers D, Nicholas H, McLellan L, Lim A, Mouliere F, Pardo OE, Ferguson V, Seckl MJ. Coombes RC, et al. Among authors: mouliere f. Nat Commun. 2022 Jun 10;13(1):3246. doi: 10.1038/s41467-022-30666-0. Nat Commun. 2022. PMID: 35688802 Free PMC article. Clinical Trial.
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.
Patel KM, van der Vos KE, Smith CG, Mouliere F, Tsui D, Morris J, Chandrananda D, Marass F, van den Broek D, Neal DE, Gnanapragasam VJ, Forshew T, van Rhijn BW, Massie CE, Rosenfeld N, van der Heijden MS. Patel KM, et al. Among authors: mouliere f. Sci Rep. 2017 Jul 17;7(1):5554. doi: 10.1038/s41598-017-05623-3. Sci Rep. 2017. PMID: 28717136 Free PMC article.
12 results